BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cleveland Biolabs Inc. 

10265 Carnegie Avenue

Cleveland  Ohio  44106  U.S.A.
Phone: 216-445-0814 Fax: 216-636-3429


SEARCH JOBS





Segment
Start Up





 Company News
Cleveland Biolabs Inc. (CBLI) Receives Funding Recommendation From Department Of Defense For Additional Development Proposal For Entolimod (CBLB502) As A Medical Radiation Countermeasure 4/16/2015 2:03:14 PM
Cleveland Biolabs Inc. (CBLI) Announces New U.S. Composition Of Matter Patent For CBLB612 4/2/2015 11:11:52 AM
Cleveland Biolabs Inc. (CBLI) Announces Completion Of Dosing In Phase I Study Of CBLB612 In Russian Federation 3/16/2015 11:26:11 AM
Cleveland Biolabs Inc. (CBLI) And Incuron Announce Growth Of Curaxin CBL0137 Patent Portfolio With U.S. Composition Of Matter Patent 3/3/2015 9:39:42 AM
Cleveland Biolabs Inc. (CBLI) Reports Fourth Quarter And Fiscal 2014 Financial Results And Development Progress 2/24/2015 1:02:23 PM
Cleveland Biolabs Inc. (CBLI) To Report Fourth Quarter And Fiscal Year 2014 Financial Results On February 24 2/20/2015 10:44:20 AM
Cleveland Biolabs Inc. (CBLI) Announces Receipt of Letter From NASDAQ Confirming Compliance With Minimum Bid Price Requirement 2/18/2015 7:51:36 AM
Cleveland Biolabs Inc. (CBLI) Announces Annual Meeting 2/12/2015 12:56:01 PM
Cleveland Biolabs Inc. (CBLI) Announces Expansion of Entolimod Patent Portfolio With New Composition of Matter Patents 2/11/2015 3:14:44 PM
Cleveland Biolabs Inc. (CBLI)To Present At 2015 BIO CEO & Investor Conference 2/5/2015 12:33:23 PM
12345678910...